Atlas Trials

A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis

Clinical trial NCT00308282 · COMPLETED

Trial details

NCT number
NCT00308282
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Arthritis, Rheumatoid
Start date
2006-03-28
Primary completion
2007-06-18
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.